Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/11/1999WO1999011291A1 A method of inducing apoptosis in human brain tumor cells using nerve growth factor
03/11/1999WO1999011288A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999WO1999011287A1 Ligands that modulate differentiation of mesenchymal stem cells
03/11/1999WO1999011282A1 Compositions and methods for contraception in or sterilization of mammals
03/11/1999WO1999011280A1 Integrin ligand dissociators
03/11/1999WO1999011278A1 Robinia pseudoacacia lectin and its uses
03/11/1999WO1998057990A3 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
03/11/1999WO1998057986A3 Human preprotachykinin b
03/11/1999WO1998057985A3 Human rip-interacting factor (rif)
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999WO1998057981A3 Chlamydia pneumoniae specific peptides and their use in diagnostic assays
03/11/1999WO1998056810A3 Lus-1 human protein, its production and use
03/11/1999WO1998055512A3 Smad-interacting polypeptides and their use
03/11/1999WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998054209A3 Human mast cell function-associated antigen (mafa) and uses thereof
03/11/1999WO1998053104A3 Detection of retroviral subtypes based upon envelope specific sequences
03/11/1999WO1998050547A3 Human toll-like receptor proteins, related reagents and methods
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999WO1998047914A3 Us6 gene from the human cytomegalovirus (hcmv)
03/11/1999WO1998044788A3 Animal model for evaluation of vaccines
03/11/1999WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19823432A1 Molecular imprinting of solid-supported amphiphile layer capable of undergoing reversible phase transition
03/11/1999DE19812802A1 Human transcription factor EMA
03/11/1999DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
03/11/1999CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999CA2303419A1 Dna molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby
03/11/1999CA2303418A1 Dna participating in regulation of expression o pebp2 .alpha.a gene, and use thereof
03/11/1999CA2302865A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria
03/11/1999CA2302829A1 An alpha-2 macroglobulin diagnostic test
03/11/1999CA2302480A1 A cell-free replication system and uses thereof
03/11/1999CA2302472A1 Randomly generated glycopeptide combinatorial libraries
03/11/1999CA2302403A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999CA2302394A1 Polypeptides comprising a coiled-coil and an addition site
03/11/1999CA2301981A1 Biomolecules comprising an elastomeric peptide
03/11/1999CA2301882A1 Genetically engineered cells which express bone morphogenetic proteins
03/11/1999CA2301848A1 Robinia pseudoacacia lectin and its uses
03/11/1999CA2301846A1 Modular protein libraries and methods of preparation
03/11/1999CA2301157A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900842A2 Artificially synthesized gene for trypsin inhibitor
03/10/1999EP0900841A1 LAG-3 splice variants
03/10/1999EP0900804A2 Analogs for specific oligosaccharide-protein interactions and uses therefor
03/10/1999EP0900521A1 Insecticidal proteins
03/10/1999EP0900384A2 Novel treatment
03/10/1999EP0900383A1 Peptides having specific affinity to pacap type 1 receptors
03/10/1999EP0900380A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
03/10/1999EP0900282A1 $i(OB) RECEPTOR ISOFORMS AND NUCLEIC ACIDS ENCODING THEM
03/10/1999EP0900280A2 Use of a polypeptide as cell receptor for adenoviruses
03/10/1999EP0900278A1 Plant pathogen resistance genes and uses thereof
03/10/1999EP0900275A1 Methods and reagents for modulating apoptosis
03/10/1999EP0900274A1 MUTANT $i(AEQUOREA VICTORIA) FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE
03/10/1999EP0900273A2 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900232A1 High molecular weight surface proteins of non-typeable haemophilus
03/10/1999EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof
03/10/1999EP0900229A1 Novel compounds
03/10/1999EP0900025A1 $i(MORAXELLA CATARRHALIS) OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
03/10/1999EP0900002A1 H2-m modified transgenic animals
03/10/1999EP0708922B1 Identification of ligands by selective amplification of cells transfected with receptors
03/10/1999EP0703783A4 Hla-a2.1 binding peptides and their uses
03/10/1999EP0644899B1 Production of recombinant human lactoferrin
03/10/1999EP0548214B1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS
03/10/1999EP0494158B1 A recombinant birth control vaccine
03/10/1999CN1210558A Recombinant phages
03/10/1999CN1210543A Synthesis of VIP analog
03/10/1999CN1210470A Vacciness against varicella zoster virus gene 63 product
03/10/1999CN1210150A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
03/10/1999CA2243670A1 Novel histidine kinase
03/09/1999US5880333 Transforming plants with vectors which encode receptor polypeptides of class ii steroid and thyroid superfamily, applying chemical which binds to receptor polypeptides and activates target vector gene expression
03/09/1999US5880331 Use of anthocyanin genes to maintain male sterile plants
03/09/1999US5880330 Tissue-specific promoter isolated from the unusual floral organ gene (ufo). genes include those involved in flowering, as well as genes that protect against pathogens by encoding toxins.
03/09/1999US5880329 Transgenic plants exhibit broad spectrum virus resistance. they include monocots, such as cereal crops, and dicot plants.
03/09/1999US5880328 Anti-pathogenic sequences derived from novel cdnas coding for pr proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease
03/09/1999US5880327 Production of clinically useful quantities of proteins.
03/09/1999US5880276 Nucleotide sequence comprising a constitutive transport enhancer which functions to transport mrna transcripts from the nucleus to the cytoplasm of a cell.
03/09/1999US5880275 Synthetic plant genes from BT kurstaki and method for preparation
03/09/1999US5880268 Modulators of the interaction between ICAM-R and αd /CD18
03/09/1999US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists
03/09/1999US5880265 Isolating factor viii and recombinants by anion exchange chromotography resulting in highly pure von willebrand factor having structural integrity, stability and no proteolytic degradation
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880262 Response regulator polypeptides from streptococcus pneumoniae; for diagnosis of bacterial infections including otitis media and meningitis; for screening of new antibiotics, bactericides
03/09/1999US5880261 Diagnosis, and prophylactic and therapeutic treatment of conditions such as diabetes and neurological diseases such as dementia and/or parkinsonism.
03/09/1999US5880260 Dopamine receptors and genes
03/09/1999US5880259 Peptide useful as a ligand
03/09/1999US5880258 Higher anti-thrombin activity by sulfating the hydroxyl group of tyrosine residues; mutant amino acid sequence allows more efficient enzyme sulfation
03/09/1999US5880256 Inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of factor viia, factor xia, plasma kallikrein, or plasmin is indicated.
03/09/1999US5880110 Production of cotton fibers with improved fiber characteristics by treatment with brassinosteroids
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999US5880103 Administering to mammal nucleic acid which expresses immunogenic peptide within cell to elicit t-cell mediated immune response
03/09/1999US5880096 Peptides and compounds that bind to the IL-1 receptor
03/09/1999US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
03/09/1999US5880094 Polypeptides that stimulate bone growth
03/09/1999US5880092 Conformationally stabilized cell adhesion peptides